Intuitive Surgical (NASDAQ:ISRG) Coverage Initiated at CICC Research

Research analysts at CICC Research assumed coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a report released on Monday. The brokerage set a “neutral” rating and a $550.00 price target on the medical equipment provider’s stock. CICC Research’s target price would indicate a potential downside of 4.20% from the stock’s previous close.

Several other research analysts have also recently commented on ISRG. BTIG Research raised their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Up 0.1 %

Shares of Intuitive Surgical stock opened at $574.14 on Monday. Intuitive Surgical has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market capitalization of $204.50 billion, a PE ratio of 92.31, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock’s fifty day moving average is $548.00 and its 200-day moving average is $506.12.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 28,749 shares of company stock valued at $15,303,875 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors have recently added to or reduced their stakes in the stock. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth about $26,000. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the third quarter worth about $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.